Invex Therapeutics Ltd (IXC.AX)
AUD 0.07
(-10.67%)
AUD 0.07
(-10.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -6.02 Million AUD | 73.19% |
| 2023 | -22.47 Million AUD | 23.41% |
| 2022 | -29.33 Million AUD | 10.32% |
| 2021 | -32.71 Million AUD | -24.39% |
| 2020 | -26.3 Million AUD | -116.1% |
| 2019 | -12.17 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -6.02 Million AUD | 73.19% |
| 2024 Q2 | -6.15 Million AUD | 0.0% |
| 2024 Q4 | -6.02 Million AUD | 0.0% |
| 2023 Q1 | -25.42 Million AUD | 13.35% |
| 2023 Q4 | -22.47 Million AUD | 0.0% |
| 2023 Q2 | -25.42 Million AUD | 0.0% |
| 2023 Q3 | -22.47 Million AUD | 11.62% |
| 2023 FY | -22.47 Million AUD | 23.41% |
| 2022 FY | -29.33 Million AUD | 10.32% |
| 2022 Q4 | -29.33 Million AUD | 0.0% |
| 2022 Q3 | -29.33 Million AUD | 6.46% |
| 2022 Q2 | -31.36 Million AUD | 0.0% |
| 2022 Q1 | -31.36 Million AUD | 4.13% |
| 2021 Q1 | -33.58 Million AUD | -27.69% |
| 2021 FY | -32.71 Million AUD | -24.39% |
| 2021 Q4 | -32.71 Million AUD | 0.0% |
| 2021 Q3 | -32.71 Million AUD | 2.58% |
| 2021 Q2 | -33.58 Million AUD | 0.0% |
| 2020 Q3 | -26.3 Million AUD | -142.55% |
| 2020 Q2 | -10.84 Million AUD | 0.0% |
| 2020 Q1 | -10.84 Million AUD | 0.0% |
| 2020 FY | -26.3 Million AUD | -116.1% |
| 2020 Q4 | -26.3 Million AUD | 0.0% |
| 2019 FY | -12.17 Million AUD | 0.0% |
| 2019 Q3 | -499.34 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 68.119% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -513.484% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 218.9% |
| Biome Australia Limited | -1.56 Million AUD | -285.529% |
| Patrys Limited | -2.24 Million AUD | -168.897% |
| Orthocell Limited | -19.92 Million AUD | 69.761% |
| Imugene Limited | -91.56 Million AUD | 93.42% |
| Noxopharm Limited | -2.31 Million AUD | -159.709% |
| PYC Therapeutics Limited | -65.76 Million AUD | 90.838% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -97.349% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 40.714% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 4.725% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 2.906% |
| CSL Limited | 15.76 Billion AUD | 100.038% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 52.612% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -749.13% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 96.707% |
| Starpharma Holdings Limited | -19.83 Million AUD | 69.619% |
| Nanollose Limited | -96.22 Thousand AUD | -6161.437% |
| Memphasys Limited | 4.13 Million AUD | 245.696% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -21.617% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -230.396% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 92.403% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -386.517% |
| Race Oncology Limited | -17.18 Million AUD | 64.948% |
| Nyrada Inc. | -4.76 Million AUD | -26.328% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 94.305% |
| Dimerix Limited | -21.99 Million AUD | 72.603% |
| PharmAust Limited | -9.71 Million AUD | 37.976% |
| Immutep Limited | -122.18 Million AUD | 95.069% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 95.586% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 51.722% |
| BTC Health Limited | -2.02 Million AUD | -197.953% |
| Acrux Limited | -1.45 Million AUD | -313.242% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 64.753% |
| Biotron Limited | -386.06 Thousand AUD | -1460.624% |
| Tissue Repair Ltd | -16.44 Million AUD | 63.354% |
| AdAlta Limited | -845.17 Thousand AUD | -612.88% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 67.564% |
| Hexima Limited | -2.22 Million AUD | -170.642% |
| AnteoTech Limited | -5 Million AUD | -20.465% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 65.731% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -77.41% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -13.057% |
| Actinogen Medical Limited | -9.13 Million AUD | 34.02% |
| Immuron Limited | -11.48 Million AUD | 47.534% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 62.137% |